期刊文献+

β射线局部照射对冠状动脉弥漫性支架内再狭窄的疗效

Clinical effects of intracoronary brachytherapy on diffuse in-stent restenosis after coronary angioplasty
下载PDF
导出
摘要 目的 探讨 β射线 (90 Sr 90 Y)对冠状动脉 (简称冠脉 )弥漫性支架内再狭窄的疗效。方法  39例经皮冠脉介入术 (PCI)及支架置入术后支架内再狭窄患者 ,随机分为支架内放射治疗组 (治疗组 ) 18例及单纯球囊组 (对照组 ) 2 1例。 2组患者再狭窄病变先经充分球囊扩张 ,治疗组用Beta Cath系统进行冠脉内放射治疗。术后随访 9个月。结果 治疗组 1例 (5 6 % )研究段血管再狭窄 ,对照组有 8例 (38 1% )再狭窄 ,两组间差异有显著性 (P =0 0 0 6 )。结论 β射线治疗冠脉弥漫性支架内再狭窄安全、有效、可行。 Objective To investigate the effect of intracoronary brachytherapy using 90 Sr/ 90 Y on in-stent restenosis in patients with coronary disease. Methods Thirty-nine patients (male 29 ,female 10) with in-stent restenosis after percutaneous coronary intervention (PCI) were studied. The patients were divided randomly into two groups: single-balloon group(21 cases,control group) and brachytherapy group(18 cases,treatment group). All the lesions were treated with balloon angioplasty satisfactorily. After that the patients in treatment group took a brachytherapy using the Beta-Cath system(Novoste). After the operation,there was a 9-months follow-up. Results Within the follow-up,one case (5.6%) in treatment group was found to be with in-stent restenosis and 8 cases(38.1%) in control group. There was significant difference between the two groups(P=0.006). Conclusion The brachytherapy using 90 Sr/ 90 Y after balloon angioplasty is safe,effective and feasible for containing diffuse in-stent restenosis in patients.
机构地区 广东省人民医院
出处 《中华核医学杂志》 CAS CSCD 北大核心 2004年第4期232-233,共2页 Chinese Journal of Nuclear Medicine
关键词 支架内再狭窄 弥漫性 冠脉 治疗组 Β射线 冠状动脉 局部照射 结论 显著性 目的 Coronary disease Stents Hyperplasia Brachytherapy Strontium radioisotopes Yttrium radioisotopes
  • 相关文献

参考文献10

  • 1刘海波,徐波,主编.冠心病介入治疗--从临床试验到临床实践. 北京:人民卫生出版社, 2001. 156-157.
  • 2Waksman R, Raizner AE, Yeung AC, et al. Use of localised intracoronary beta radiation in treatment of in-stent restenosis: the INHIBIT randomised controlled trial. Lancet, 2002, 359: 551-557.
  • 3Mehran R, Dangas G, Andrea S, et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation, 1999, 100: 1872-1878.
  • 4Morino Y, Kaneda H, Fox T, et al. Delivered dose and vascular response after β-radiation for in-stent restenosis. Circulation, 2002, 106: 2334-2339.
  • 5Fishman DL, Leon MB, Bain DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med, 1994, 331: 496-501.
  • 6Waksman R, Rhargava B, White RL, et al. Intracoronary radiation for patients with refractory in-stent restenosis. An analysis from the WRIST-Crossover trial. Washington radiation for in-stent restenosis trial. Cardiovasc Radiat Med, 2001, 1: 317-322.
  • 7Waksman R, Bhargava B, White L, et al. Intracoronary beta-radiation therapy inhibits resurrence of instent restenosis. Circulation, 2000, 101: 1895-1898.
  • 8Suntharalingam M, Laskey W, Lansky AJ, et al. Clinical and angiographic outcomes after use 90 Sr/ 90Y beta radiation for the treatment of in-stent restenosis: results from the stents and radiation therapy 40 (START 40) registry. Int J Radiat Oncol Biol Phys. 2002, 52: 1075-1082.
  • 9Sabate M, Kay IP, Gijzel AL, et al. Compassionate use of intracoronary beta irradiation for treatment of recurrent in-stent restenosis. J Invas Cardiol, 1999, 11: 582-588.
  • 10陈绍良,段宝祥,叶飞,宋杰,刘志忠.血管内β照射治疗后边缘现象及近期疗效的研究[J].中华核医学杂志,2003,23(1):47-49. 被引量:2

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部